Drug profile · INN
calcium oxybate
XYWAV
calcium oxybate (XYWAV) is a gaba-b receptor agonist. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
Drug details — calcium oxybate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 1
- Data quality
- 0.89
Quick answer
calcium oxybate (XYWAV) is a gaba-b receptor agonist. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-B receptor agonist
Primary target: GABA-B receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12138233
Methods of treating idiopathic hypersomnia
granted -
US 11986446
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 11554102
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
granted -
US 11426373
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
granted -
US 11413264
Carbamoyl phenylalaninol analogs and uses thereof
granted -
US 11253494
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 11149000
Carbamoyl phenylalaninol compounds and uses thereof
granted -
US 10864181
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 10710958
Carbamoyl phenylalaninol compounds and uses thereof
granted -
US 10675258
Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
granted -
US 10213400
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 10195168
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
granted -
US 9707270
Method for administering ω-conopeptide
granted -
US 9555017
Methods of making a mixture of salts of gamma-hydroxybutyrate
granted -
US 9486426
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 9132107
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
granted -
US 9050302
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 8901173
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
granted -
US 8772306
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 8765680
Method for administering omega-conopeptide
granted
Frequently asked questions
What is calcium oxybate?
calcium oxybate (XYWAV) is a gaba-b receptor agonist. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for calcium oxybate?
XYWAV is a marketed brand name for calcium oxybate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calcium oxybate?
calcium oxybate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.